Janus Henderson Group
IMMU

Janus Henderson Group’s Immunomedics Inc IMMU Stock Holding History

Janus Henderson Group’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,320,782
Closed -$46.8M – 1391
2020
Q2 		$46.8M Sell
1,320,782
-1,284,788
-49% -$37.6M 0.03% 503
2020
Q1 		$35.1M Sell
2,605,570
-1,097,094
-30% -$18.5M 0.02% 539
2019
Q4 		$78.3M Sell
3,702,664
-241,845
-6% -$4.27M 0.04% 452
2019
Q3 		$52.3M Sell
3,944,509
-11,780
-0.3% -$173K 0.03% 562
2019
Q2 		$54.9M Buy
3,956,289
+124,387
+3% +$1.87M 0.03% 548
2019
Q1 		$73.6M Sell
3,831,902
-10,992
-0.3% -$177K 0.04% 472
2018
Q4 		$54.8M Buy
3,842,894
+202,595
+6% +$4.02M 0.04% 512
2018
Q3 		$75.8M Buy
3,640,299
+422,540
+13% +$10M 0.04% 469
2018
Q2 		$76.2M Buy
3,217,759
+1,284,303
+66% +$25.8M 0.04% 447
2018
Q1 		$28.2M Buy
1,933,456
+415,121
+27% +$6.78M 0.02% 705
2017
Q4 		$24.5M Buy
+1,518,335
New +$17.9M 0.01% 707

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Janus Henderson Group's IMMU Position: Q3 2020 in Review

Janus Henderson Group sold out of Immunomedics Inc (IMMU) in Q3 2020, closing a stake of 1,320,782 shares — an estimated $46.8M sold.

Janus Henderson Group first reported a position in IMMU in Q4 2017 and held it in 11 quarters. The position peaked at $78.3M in Q4 2019. 408 funds tracked by Wall St. Rank hold IMMU as of Q3 2020.

  • Janus Henderson Group reported no remaining Immunomedics Inc position as of Q3 2020 after selling out during the quarter.
  • Janus Henderson Group sold 1,320,782 Immunomedics Inc shares in Q3 2020, an estimated $46.8M.
  • Janus Henderson Group first reported a position in Immunomedics Inc in Q4 2017 and held it in 11 quarters.
  • Janus Henderson Group's Immunomedics Inc position peaked at $78.3M in Q4 2019.
  • 408 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2020.

Based on Janus Henderson Group's 13F filing for Q3 2020, filed 16 Nov 2020.